交易中 09-24 11:47:04 美东时间
-0.420
-2.85%
A U.S. federal judge has allowed Connecticut firefighters to pursue claims against more than 20 companies, including 3M (MMM) and DuPont (DD), alleging that chemicals in protective gear exposed them t...
09-16 04:25
Corteva’s (CTVA) crop-protection business is counting on new products, biological treatments and artificial intelligence to overcome growing competition after its planned separation from seed company ...
09-15 23:38
The Chemours Company (NYSE:CC) shares traded higher Thursday after the company, DuPont, and Corteva reached a $455 million settlement resolving PFAS-related litigation in North Carolina. The gain came despite broader weakness, with the S&P 500 down 0.43% and the Materials sector falling 1.24%. Chemo...
09-11 00:26
DuPont de Nemours (DD), Chemours (CC) and Corteva (CTVA) agreed to pay $455 million to settle claims involving PFAS contamination in North Carolina, including discharges tied to the Fayetteville Works...
09-10 19:48
Chemours Company ( ($CC) ) has issued an update. On September 9, 2026, Chemours...
09-10 19:18
An announcement from Chemours Company ( ($CC) ) is now available. On September ...
09-09 18:58
华盛资讯9月9日讯,The Chemours公布2026财年Q2业绩,公司Q2营收15.91亿美元,同比下降1.5%,归母净利润亏损2.74亿美元,同比亏损缩窄27.9%。
09-09 18:47
3M (MMM) stock has extended its decline this week, falling roughly 4% from the ~$175 area to around $167.92 on Friday. The decline has pushed the stock deeper into a short-term downtrend, with investo...
09-05 02:08
CSX Corp. announced the recipients of its 32nd annual Chemical Safety Excellence Awards, recognizing 55 customers for outstanding performance in the safe transportation of hazardous materials. The awards honor customers who shipped at least 600 carloads of hazardous materials on the CSX network in 2025 without a controllable hazardous materials release. CSX also recognized customers achieving milestone anniversaries without a controllable hazardo...
08-27 13:00
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45